Pre-clinical studies have also implicated IL-6 in impaired immune responses, arthritis, colitis, and multiple sclerosis and activation of mucosal T cells induced by IL-6-sIL-6R exacerbates Crohn disease, a chronic inflammatory disease of the gastrointestinal tract chronic intestinal inflammation (22–26). Here, IL6 is linked to multiple sclerosis.